Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial

Actual versus ideal body weight dosing of sugammadex in morbidly obese patients offers faster reversal of rocuronium- or vecuronium-induced deep or moderate neuromuscular block: a randomized clinical trial

Abstract Background This randomized, double-blind trial evaluated sugammadex-mediated recovery time from rocuronium- or vecuronium-induced moderate (M-) or deep (D-) neuromuscular block in morbidly obese adults dosed by actual (ABW) or ideal body weight (IBW). Methods Adults with BMI ≥40 kg/m2 were...

Full description

Bibliographic Details
Main Authors: Jay C. Horrow, Wen Li, Manfred Blobner, John Lombard, Marcel Speek, Matthew DeAngelis, W. Joseph Herring
Format: Article
Language:English
Published: BMC 2021-02-01
Series:BMC Anesthesiology
Subjects:
Recurarization
Bradycardia
Neostigmine
Multicenter trial
Online Access:https://doi.org/10.1186/s12871-021-01278-w

Internet

https://doi.org/10.1186/s12871-021-01278-w

Similar Items